Recent News Articles
Uganda loses more than US$1.1billion annually due ...Read More
In this report, we profile the work of renown Make...Read More
Prevention of infectious diseases in beef cattle t...Read More
June 28, 2022 at 2:26 pm by Admin
Ugandan farmers who could switch up their herd to European exotic cattle breeds could viably increase their income ten-fold. This is because exotic cows on average, produce 10-30 times more milk than indigenous Ugandan ones. Yet nine out of ten (93%) cattle herds reared for milk production in Uganda are native cattle breeds. The low uptake of exotic cows is keeping the sector underdeveloped and underutilised. Some of the major reasons given by many farmers for their reluctance to switch to exotic cows is their higher maintenance cost especially via feeding, and their vulnerability to the fatal East Coast Fever. It kills over 1million cattle annually in Africa—that's one cow every 30 seconds. It is especially deadly to untreated non-native cattle and their crossbreeds. However, Ugandan cows could soon be made immune to East Coast Fever and other prevalent tickborne pathogenic diseases, potentially transforming Uganda’s livestock sector, optimising the efficiency of milk and meat production from livestock in the country.
The Anti-Tick Vaccine Development Initiative is at the forefront of research to deliver an innovative alternative immunological solution that advances the prevention and treatment of one of Uganda’s most challenging livestock problem – tick borne diseases. We are the makers of TicVac-U, the first anti-tick vaccine researched, developed and manufactured in Uganda.Read more
Working together with the Government of Uganda, Makerere University, College of Veterinary Medicine, Animal Resources and Bio-security (COVAB), National Drug Authority (NDA) and other stakeholders, our vision is to eradicate the problems of ticks in Uganda first, then globally, working towards a tick free world.
Our mission is to contribute to the control of ticks and tick-borne diseases by offering innovative alternative immunological control, research, manufacture and distribution of critical veterinary vaccines that will make a positive difference to Uganda’s livestock, the people that depend on them and the country’s economy.
Dr. Margaret Saimo-Kahwa
B.VetMed, Msc, PhD. Principle Investigator, Anti-Tick Vaccine Development Initiative. Senior Lecturer at the College of Veterinary Medicine, Animal Resources and Bio-security (COVAB).View Details
Dr. Kokas Ikwap
BVM, MSc in Molecular Biology & Biotechnology. Scientist/Parasitologist at the TicVac Anti-Tick Vaccine Development Initiative.View Details
Dr. Sylvester Ochwo
B.VetMed, MSc, PhD in Veterinary Epidemiology . Dr Sylvester Ochwo is a Scientist aka Molecular Biologist at the TicVac Anti-Tick Vaccine Development Initiative.View Details
Mr. Peregrine Sebulime
BVM, Msc in Biological Sciences. Lecturer, Department of Wildlife and Aquatic Animal Resources, MAK. Scientist at the TicVac Anti-Tick Vaccine Development Initiative.View Details